The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer.
about
Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.Prognostic significance of preoperative fibrinogen in patients with colon cancerPatterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome StudyThe relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.Does vitamin D affect risk of developing autoimmune disease?: a systematic review.The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response.Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.Postoperative simple biochemical markers for prediction of bone metastases in Egyptian breast cancer patients.An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).Prognostic evaluation of preoperative serum C-reactive protein concentration in patients with epithelial ovarian cancer.Comparison of Inflammation-Based Prognostic Scores in a Cohort of Patients with Resectable Esophageal CancerEvaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy.Performance Status, Prognostic Scoring, and Parenteral Nutrition Requirements Predict Survival in Patients with Advanced Cancer Receiving Home Parenteral Nutrition.High preoperative Glasgow prognostic score is a negative prognostic factor for patients with endometrial carcinoma.Association between unexplained hypoalbuminaemia and new cancer diagnoses in UK primary care patients.Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer.Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction.Evaluation of surgical outcome scores according to ISGPS definitions in patients undergoing pancreatic resection.
P2860
Q33673109-96C15CB2-3771-4A5C-9AA9-81039AC91BB8Q33710746-6292A7DA-212B-4F11-90FE-D79CA7D93525Q33887040-8BC3EDDC-B63E-44BE-9C44-448329B04E74Q34173277-393D2029-6A26-4024-883D-972EDC7204BDQ34253740-7C3AB5D7-4EEA-49D6-9AE6-D85840EF515EQ34369105-80157C27-2BF3-449A-89F2-9073E44CA3F4Q34995500-E2D159CC-8A5D-401E-92D5-0DF8DB9D6CEBQ35609756-B52B7AC0-4FC6-4C2E-B3E7-8A2477E99335Q35623609-6234929B-95F8-48DF-9A97-15DB2A4042CAQ36290407-D9F59570-36E8-4606-A92B-187C3B28CFE6Q36412149-D82A13AA-269C-48D6-BCAC-48F8543480D0Q36807447-0C58594D-966D-49CC-BE6E-27A880D00714Q37152934-68F2769E-3BB4-48D0-ACB5-9C4526F7A137Q37683517-1825C83E-CF2C-4AA1-A663-29EFE7101A88Q38674509-B9F0C889-449F-469A-9CD0-9AFE9AF5651CQ40774077-B092AB09-2732-4968-8E0C-01FFE4D68B40Q40979708-8204D2C9-E615-4D51-810A-740A57973220Q41213007-296E015F-CE40-44A7-B17E-0FB55CEB8127Q41900633-AC8D41DC-DBEB-466D-9351-1F1CB8403281Q47947363-83B83B21-CC5C-4895-9C6A-B3E5FD2D573BQ48350973-BF9D588F-5F94-4594-86B5-46FA275A98CBQ49873955-DAC7BD01-5C63-47B7-98A3-C80347D0482EQ50201562-CF75665A-290B-45A1-87FE-004D3E541E43Q50508477-B5383DB8-BC09-4D76-8294-F3A6048A8875Q50661411-9877A220-8822-4EF0-8A00-0F599E08C787Q50892714-0B562CAA-2E22-4CD6-87AB-00ABE95277DDQ51009416-E731F876-1474-4290-B35D-CDA233C19483Q53166298-316BA96A-60C7-4C3D-886A-F9DF5595D1BA
P2860
The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The relationship between an in ...... g and gastrointestinal cancer.
@ast
The relationship between an in ...... g and gastrointestinal cancer.
@en
type
label
The relationship between an in ...... g and gastrointestinal cancer.
@ast
The relationship between an in ...... g and gastrointestinal cancer.
@en
prefLabel
The relationship between an in ...... g and gastrointestinal cancer.
@ast
The relationship between an in ...... g and gastrointestinal cancer.
@en
P2093
P2860
P356
P1476
The relationship between an in ...... g and gastrointestinal cancer.
@en
P2093
P2860
P304
P356
10.1136/JCP.2005.033217
P407
P577
2006-04-27T00:00:00Z